JP2016520068A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520068A5
JP2016520068A5 JP2016513108A JP2016513108A JP2016520068A5 JP 2016520068 A5 JP2016520068 A5 JP 2016520068A5 JP 2016513108 A JP2016513108 A JP 2016513108A JP 2016513108 A JP2016513108 A JP 2016513108A JP 2016520068 A5 JP2016520068 A5 JP 2016520068A5
Authority
JP
Japan
Prior art keywords
scaffold
stem cells
abcb5
wound healing
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513108A
Other languages
English (en)
Japanese (ja)
Other versions
JP6600299B2 (ja
JP2016520068A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037435 external-priority patent/WO2014182994A1/en
Publication of JP2016520068A publication Critical patent/JP2016520068A/ja
Publication of JP2016520068A5 publication Critical patent/JP2016520068A5/ja
Application granted granted Critical
Publication of JP6600299B2 publication Critical patent/JP6600299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513108A 2013-05-10 2014-05-09 創傷治癒および組織工学 Active JP6600299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822134P 2013-05-10 2013-05-10
US61/822,134 2013-05-10
PCT/US2014/037435 WO2014182994A1 (en) 2013-05-10 2014-05-09 Wound healing and tissue engineering

Publications (3)

Publication Number Publication Date
JP2016520068A JP2016520068A (ja) 2016-07-11
JP2016520068A5 true JP2016520068A5 (enExample) 2017-06-22
JP6600299B2 JP6600299B2 (ja) 2019-10-30

Family

ID=51867763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016513108A Active JP6600299B2 (ja) 2013-05-10 2014-05-09 創傷治癒および組織工学

Country Status (12)

Country Link
US (2) US11446331B2 (enExample)
EP (2) EP4008369A1 (enExample)
JP (1) JP6600299B2 (enExample)
KR (1) KR102319899B1 (enExample)
CN (1) CN105517587B (enExample)
AU (1) AU2014262590B2 (enExample)
BR (1) BR112015028193B8 (enExample)
CA (1) CA2911232C (enExample)
DK (1) DK2994173T3 (enExample)
ES (1) ES2892403T3 (enExample)
MX (1) MX378814B (enExample)
WO (1) WO2014182994A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2411101C (en) 2000-06-05 2018-01-16 Brigham And Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
WO2007143139A1 (en) 2006-05-31 2007-12-13 The Brigham And Women's Hospital, Inc. Abcb5 positive mesenchymal stem cells as immunomodulators
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
US9801912B2 (en) 2013-02-19 2017-10-31 Va Boston Healthcare System ABCB5(+) stem cells for treating ocular disease
BR112015028193B8 (pt) 2013-05-10 2023-04-18 Childrens Medical Center Suporte para cicatrização de feridas
CA2966431C (en) * 2014-10-31 2023-02-14 The Administrators Of The Tulane Educational Fund Surgical grafts for replacing the nipple and areola or damaged epidermis
US20200038248A1 (en) * 2016-10-05 2020-02-06 Temple University- Of The Commonwealth System Of Higher Education Negative Pressure Enhanced Cellular Infiltration
CN107050521B (zh) * 2017-04-27 2020-10-09 天新福(北京)医疗器材股份有限公司 一种双层胶原真皮支架及其制备方法
KR20210005118A (ko) * 2018-04-25 2021-01-13 칠드런'즈 메디컬 센터 코포레이션 Abcb5 리간드 및 기질
US11090412B2 (en) 2018-12-21 2021-08-17 Zavation Medical Products Llc Bone repair composition and kit
KR20220007596A (ko) * 2019-03-28 2022-01-18 칠드런'즈 메디컬 센터 코포레이션 고도로 기능적인 제조된 abcb5+ 중간엽 줄기 세포
US20220241339A1 (en) * 2019-04-24 2022-08-04 Children's Medical Center Corporation Abcb5+ stem cell therapeutics for liver disease
CN110314252A (zh) * 2019-05-22 2019-10-11 嘉兴市爵拓科技有限公司 胶原蛋白植入物在制备青光眼手术辅助复原物中的用途
EP4125960A4 (en) * 2020-03-30 2024-04-03 Children's Medical Center Corporation USING STEM CELLS TO TREAT EXCESSIVE INFLAMMATION
GB2605969A (en) * 2021-04-19 2022-10-26 The Griffin Inst Skin membranes

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280954A (en) 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4382441A (en) 1978-12-06 1983-05-10 Svedman Paul Device for treating tissues, for example skin
US4505266A (en) 1981-10-26 1985-03-19 Massachusetts Institute Of Technology Method of using a fibrous lattice
GB8509978D0 (en) 1985-04-18 1985-05-30 Juhasz L Wound dressings
US5434075A (en) 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
GB2272645B8 (en) 1992-11-23 2010-02-10 Johnson & Johnson Medical Wound dressing
GB9403135D0 (en) 1994-02-18 1994-04-06 Univ Glasgow Wound healing device
US5489304A (en) * 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5906934A (en) 1995-03-14 1999-05-25 Morphogen Pharmaceuticals, Inc. Mesenchymal stem cells for cartilage repair
ATE439849T1 (de) 1996-04-19 2009-09-15 Osiris Therapeutics Inc Die wiederherstellung und verstärkung von knochen mittels mesenchymalen stammzellen
US5904659A (en) 1997-02-14 1999-05-18 Exogen, Inc. Ultrasonic treatment for wounds
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
DE19722075C1 (de) 1997-05-27 1998-10-01 Wilhelm Dr Med Fleischmann Vorrichtung zur Applikation von Wirkstoffen an einer Wundoberfläche
EP1062321B1 (en) 1998-03-13 2004-12-29 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6797269B2 (en) 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
EP1082410B1 (en) 1998-05-29 2007-08-01 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
WO2001037922A2 (en) 1999-11-29 2001-05-31 Hill-Rom Services, Inc. Wound treatment apparatus
US6673606B1 (en) 2000-04-12 2004-01-06 The Children's Hospital Of Philadelphia Therapeutic uses for mesenchymal stromal cells
CA2411101C (en) 2000-06-05 2018-01-16 Brigham And Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
EP1322936A2 (en) 2000-10-03 2003-07-02 California Institute Of Technology Microfluidic devices and methods of use
WO2002083046A1 (en) 2001-04-16 2002-10-24 Pamela Howard Wound dressing system
US6905678B2 (en) 2001-07-07 2005-06-14 Crucell Holland B.V. Gene delivery vectors with cell type specificity for mesenchymal stem cells
US8034904B2 (en) 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US20040175366A1 (en) 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
CA2629330C (en) 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
AU2006304392B2 (en) 2005-10-18 2014-05-01 National Jewish Health Conditionally immortalized long-term stem cells and methods of making and using such cells
WO2007143139A1 (en) 2006-05-31 2007-12-13 The Brigham And Women's Hospital, Inc. Abcb5 positive mesenchymal stem cells as immunomodulators
GB0610778D0 (en) 2006-05-31 2006-07-12 Het Nl Kanker I Phosphatidylinositol phospahte and apoptosis
WO2008064244A2 (en) 2006-11-20 2008-05-29 The Trustees Of Columbia University In The City Of New York Phosphoinositide modulation for the treatment of neurodegenerative diseases
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
US9011840B2 (en) * 2008-03-14 2015-04-21 The Board Of Trustees Of The University Of Illinois Activated mesenchymal stem cells for wound healing and impaired tissue regeneration
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
WO2010065711A1 (en) 2008-12-04 2010-06-10 Adimab, Inc. An abcb5 epitope and antibodies thereto for the treatment of cancer
GB0908927D0 (en) 2009-05-22 2009-07-01 Univ Reading The Synthetic graft
US9814744B2 (en) * 2009-12-22 2017-11-14 University of Pittsburg—Of the Commonwealth System of Higher Education Decellularized adipose cell growth scaffold
WO2013002953A1 (en) * 2011-06-01 2013-01-03 The Board Of Trustees Of The University Of Illinois Membrane-scaffold composites for tissue engineering applications
KR101138091B1 (ko) 2011-08-31 2012-04-24 세원셀론텍(주) 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제
US9801912B2 (en) 2013-02-19 2017-10-31 Va Boston Healthcare System ABCB5(+) stem cells for treating ocular disease
BR112015028193B8 (pt) 2013-05-10 2023-04-18 Childrens Medical Center Suporte para cicatrização de feridas
US20180134771A1 (en) 2015-05-07 2018-05-17 Bioxcel Corporation Novel immunomodulatory therapeutic strategies targeting tumors in cancer
KR20210005118A (ko) 2018-04-25 2021-01-13 칠드런'즈 메디컬 센터 코포레이션 Abcb5 리간드 및 기질
KR20220007596A (ko) 2019-03-28 2022-01-18 칠드런'즈 메디컬 센터 코포레이션 고도로 기능적인 제조된 abcb5+ 중간엽 줄기 세포

Similar Documents

Publication Publication Date Title
JP2016520068A5 (enExample)
Vig et al. Advances in skin regeneration using tissue engineering
Tong et al. Hypoxia pretreatment of bone marrow—derived mesenchymal stem cells seeded in a collagen‐chitosan sponge scaffold promotes skin wound healing in diabetic rats with hindlimb ischemia
Ilic et al. Human amniotic membrane grafts in therapy of chronic non-healing wounds
Cerqueira et al. Human adipose stem cells cell sheet constructs impact epidermal morphogenesis in full-thickness excisional wounds
Swartzlander et al. Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden synthetic hydrogels
Rennert et al. Biological therapies for the treatment of cutaneous wounds: phase III and launched therapies
Ingraldi et al. The preparation and clinical efficacy of amnion-derived membranes: a review
IL320440A (en) Methods of in vitro differentiation of midbrain dopamine (mda) neurons
WO2014040026A3 (en) Amniotic membrane and its use in wound healing and tissue engineering constructs
CU24495B1 (es) Compuestos que expanden las células hematopoyéticas y método ex vivo para expandir las células hematopoyéticas
CL2008001620A1 (es) Induccion de fenotipo tolerogenico en celulas dendriticas maduras
AR081166A1 (es) Angiogenesis por el uso de celulas madre placentarias
Fitriani et al. Application of amniotic membrane in skin regeneration
ATE539145T1 (de) Verfahren zum erhalt von mesenchymalen stammzellen
EA201890516A1 (ru) Клинические композиции
BR112015028193A2 (pt) cicatrização de feridas e engenharia de tecidos
CO2021003290A2 (es) Método para obtener una población enriquecida de células madre mesenquimales funcionales, células obtenidas de la misma y composiciones que las comprenden.
JP2016536315A5 (enExample)
Ozdogan et al. An in vitro 3D diabetic human skin model from diabetic primary cells
ES3043959T3 (en) Cellular substitutes and methods of preparation thereof
WO2018155925A3 (ko) 하이드로겔 중합체를 이용한 탈세포화 조직의 제조방법 및 이로부터 제조된 탈세포화 조직
Veitinger et al. Resolution of a chronic occipital wound with exposed skull bone with a fish skin graft: a successful treatment approach
MX2021012141A (es) Composicion para regeneracion de tejidos, metodo de produccion y usos de la misma.
EA201200028A1 (ru) Альфа-1 мультимеры hla-g и их фармацевтическое применение